1. Web alert

   News Pages: 75 - 76

2. The impact of race and ethnicity on the treatment of hepatitis C disease

   • Carla W. Brady
   • Andrew J. Muir

   OriginalPaper Pages: 79 - 85

3. Fibrosis markers in hepatitis C

   • Carla W. Brady
   • John G. McHutchison
   • Keyur Patel

   OriginalPaper Pages: 86 - 93

4. Antifibrotic targets and therapy in HCV

   • Efsevia Albanis
   • Scott L. Friedman

   OriginalPaper Pages: 94 - 100

5. Treatment of HCV infection in patients with renal failure

   • Suphamai Bunnapradist
   • Fabrizio Fabrizi
   • Paul Martin

   OriginalPaper Pages: 101 - 107

6. Treatment of nonresponders to standard hepatitis C therapy

   • Maya Gambarin-Gelwan
   • Ira M. Jacobson

   OriginalPaper Pages: 108 - 113

7. Chronic hepatitis C: Treatment of pegylated interferon/ ribavirin nonresponders

   • Mitchell L. Shiffman

   OriginalPaper Pages: 114 - 120

8. Future therapies for hepatitis C

   • Asim S. Khokhar
   • Valerie Byrnes
   • Nezam H. Afdhal

   OriginalPaper Pages: 121 - 128